FEATURED NEWS
Delve presents latest findings at Pediatric Infectious Disease Society 2024 Meeting
Delve presents poster titled, “Clinical impact of metagenomic next-generation sequencing testing on cerebrospinal fluid in a pediatric cohort with suspected central nervous system infections” at the PIDS 2024 International Pediatric Antimicrobial Stewardship Conference.
Delve Neuro
Delve Neuro provides pathogen-agnostic and unbiased detection of neuro-infectious pathogens in cerebrospinal fluid (CSF) in one shot.
- Samples the entire metagenomic content – DNA and RNA – within a patient sample.
- Uses a proprietary mNGS bioinformatic pipeline to rapidly analyze millions of sequences.
- Rapidly and accurately identifies bacterial, viral, fungal, and parasitic species.
As exclusive licensee of University of California San Francisco’s (UCSF) metagenomic sequencing (mNGS) technology, Delve Bio leverages mNGS to empower labs and clinicians with the results they need to diagnose routine and rare infectious diseases.
Meet the Delve Team
Leadership
Founders
Pardis Sabeti, MD, PhD
Professor, Harvard University
Institute Member, Broad Institute
https://www.sabetilab.org
![](https://www.delve.bio/wp-content/uploads/2023/04/Rectangle-1-300x300.jpg)
Joe DeRisi, PhD
Professor, University of California San Francisco
President, Chan Zuckerberg Biohub
https://derisilab.ucsf.edu
Matthew Meyerson, MD, PhD
Director, Center for Cancer Genomics, Dana-Farber Cancer Institute
Professor of Genetics and Medicine, Harvard Medical School
Institute Member, Cancer Program, Broad Institute
https://meyersonlab.dana-farber.org
Charles Chiu, MD, PhD
Professor, Laboratory Medicine and Medicine / Infectious Diseases, University of California, San Francisco
Associate Director, UCSF Clinical Microbiology Laboratory
Investigator, Chan-Zuckerberg Biohub
https://chiulab.ucsf.edu
Board of Directors
Investors
![Xontogeny](https://www.delve.bio/wp-content/uploads/2024/05/xontegeny-logo-300x300.png)
Perceptive Xontogeny Venture Fund II
![Section 32](https://www.delve.bio/wp-content/uploads/2024/05/s32-logo-300x300.png)
Section 32
![Google Ventures](https://www.delve.bio/wp-content/uploads/2024/05/google-ventures-logo-300x300.png)
Google Ventures
News and Updates
Careers
Delve has recently been made aware of a growing number of email scams targeting job candidates in the biotech industry. Delve exclusively uses @delve.bio email addresses for any and all communication. We do not ask candidates to purchase anything, nor do we ask for any sensitive information via email. If a person claiming to represent Delve with an alternative email domain reaches out to you regarding a job posting, please report it to our team by emailing support@delve.bio with details.